About the role
- Location:
- Gaithersburg, Maryland, United States
- Work arrangement:
- Hybrid
- Employment type:
- Full-time
- Sector:
- Oncology Research & Development
- Reports to:
- Vice President, Translational Medicine or Senior Vice President, Oncology Research, depending on organizational alignment.
Company overview
AstraZeneca is a global biopharmaceutical company focused on the discovery, development and commercialization of prescription medicines across several major therapeutic areas, including oncology, cardiovascular, renal and metabolism, respiratory and immunology, and rare diseases. Its oncology research organization brings together scientists, clinicians, translational researchers and technology specialists to advance the understanding of disease biology, identify biomarkers, and translate scientific discoveries into new therapeutic approaches. The company invests in translational medicine, advanced tissue analysis, molecular characterization and precision medicine to support the development of targeted cancer treatments and improve clinical decision-making.
The opportunity
AstraZeneca is seeking an experienced Director, Translational Pathology & Biomarker Sciences to provide scientific and operational leadership across oncology research programs. This position will play an important role in connecting pathology-based research, tissue biomarker characterization and advanced imaging approaches with broader translational medicine and drug development objectives. The successful candidate will work closely with oncology discovery scientists, translational medicine teams, clinical development, bioinformatics, pathology specialists and external research partners to ensure that tissue-based scientific evidence is appropriately incorporated into research and development decisions. The Director will provide scientific direction for pathology and biomarker strategies, oversee the delivery of complex tissue-based research activities, and support the interpretation of findings that inform target validation, patient stratification and clinical development. This role requires a strong understanding of oncology research, immunohistochemistry, digital pathology, biomarker assessment and multidisciplinary scientific collaboration. It also requires the ability to guide research teams, evaluate emerging technologies and communicate complex scientific findings to senior stakeholders.
Key responsibilities
- Translational Pathology Leadership: Provide scientific leadership for pathology-based research activities supporting oncology discovery and development programs, ensuring that tissue analysis strategies are aligned with program objectives and scientific priorities.
- Biomarker Strategy: Guide the identification, characterization and evaluation of tissue-based biomarkers to support target validation, disease characterization, patient selection and translational research initiatives.
- Digital Pathology and Imaging: Oversee the application of digital pathology, advanced imaging and quantitative tissue analysis approaches to improve the consistency, quality and interpretation of research findings.
- Immunohistochemistry and Tissue Analysis: Provide scientific oversight of immunohistochemistry and related tissue characterization methods, including assay evaluation, interpretation of staining patterns and assessment of biomarker expression.
- Oncology Research Collaboration: Partner with oncology discovery, translational medicine and clinical development teams to integrate pathology and biomarker findings into broader research strategies.
- Scientific Program Oversight: Establish research priorities, review scientific deliverables and monitor the progress of multiple tissue-based research initiatives, ensuring appropriate alignment with program timelines and development milestones.
- Cross-Functional Leadership: Work with internal scientific functions, clinical teams, laboratory operations, data science and external collaborators to coordinate complex research activities and resolve scientific or operational challenges.
- Research Quality and Methodology: Promote consistent scientific standards across pathology workflows, tissue evaluation methods, data interpretation and documentation of research findings.
- External Scientific Partnerships: Establish and maintain productive working relationships with academic institutions, contract research organizations, pathology laboratories and technology providers.
- Emerging Technology Assessment: Evaluate new developments in digital pathology, image analysis, spatial biology and tissue-based biomarker technologies, identifying opportunities to strengthen research capabilities.
- Executive Scientific Communication: Present research findings, program updates, scientific recommendations and potential development implications to senior research and development leadership.
Candidate profile
- PhD, MD, DVM, or equivalent advanced degree in Pathology, Cancer Biology, Molecular Biology, Biomedical Sciences, Immunology or a closely related discipline.
- Substantial experience in oncology research, translational sciences, experimental pathology or biomarker-focused research within the pharmaceutical, biotechnology or academic healthcare research environment.
- Demonstrated experience working with tissue-based research methodologies, including immunohistochemistry and histopathological assessment.
- Strong understanding of oncology biology, biomarker characterization and the application of tissue-based evidence in drug discovery or development.
- Experience with digital pathology, advanced imaging techniques or quantitative tissue analysis.
- Demonstrated ability to lead multidisciplinary scientific projects and coordinate research activities across multiple functions.
- Experience interpreting complex experimental findings and translating scientific results into actionable research recommendations.
- Strong understanding of scientific documentation, research quality expectations and appropriate laboratory practices.
- Excellent written and verbal communication skills, including the ability to present complex scientific information to technical and nontechnical stakeholders.
- Demonstrated ability to manage competing scientific priorities while maintaining research quality and delivery timelines.
Preferred qualifications
- Previous experience in a Director-level or comparable scientific leadership position within a pharmaceutical, biotechnology or healthcare research organization.
- Experience supporting oncology drug discovery, translational medicine or early clinical development programs.
- Familiarity with biomarker strategies supporting precision oncology and patient stratification.
- Experience working with digital pathology platforms and image-analysis technologies.
- Exposure to multiplex immunohistochemistry, immunofluorescence or other advanced tissue characterization approaches.
- Experience collaborating with external pathology laboratories, academic research centers or contract research organizations.
- Familiarity with spatial biology and emerging tissue-based analytical technologies.
- Experience contributing to scientific publications, research presentations or cross-functional development reviews.
Compensation & benefits
- Estimated annual base salary: $220,000–$285,000.
- The anticipated compensation package includes:
- Annual performance-based incentive, with a target bonus of approximately 25–30%.
- Long-term equity awards, subject to eligibility and company compensation policies.
- Comprehensive medical, dental and vision insurance.
- Retirement savings plan with company contributions.
- Paid vacation, company holidays and personal leave.
- Life and disability insurance.
- Professional development and continuing education support.
- Leadership development opportunities.
- Employee wellness and assistance programs.
- Flexible working arrangements subject to business and research requirements.
- Final compensation will depend on qualifications, relevant experience, geographic location and internal compensation guidelines.
